PetMed Express Inc. Amends Inducement Plan to Grant CEO Equity

What Happened
PetMed Express, Inc. announced on September 28, 2026 (filed 8-K) that its Board approved an amendment to the company's 2024 Inducement Incentive Plan, increasing the number of shares reserved for issuance by 500,000 to a total of 850,000 shares. The increase covers equity awards the company agreed to grant to new CEO Jeffrey Allen Willard — 250,000 shares of restricted stock and 250,000 performance share units — under his employment agreement, with his start date on September 28, 2026.

Key Details

• Board adopted the amendment by amending and restating the Inducement Plan effective September 27, 2026.
• Total shares reserved under the Amended and Restated Inducement Plan: 850,000 (500,000 increase).
• The 500,000-share increase corresponds to 250,000 restricted stock and 250,000 performance share units for CEO Jeffrey Allen Willard.
• The Inducement Plan’s terms are substantially similar to the company’s 2024 Omnibus Incentive Plan but are limited to new hires in accordance with Nasdaq’s inducement award exception.

Why It Matters
This filing formalizes the equity component of the new CEO’s compensation and increases potential share dilution by 500,000 shares (the specific dilution effect depends on outstanding shares). For investors, the change signals the company is using equity incentives to recruit and retain executive leadership; shareholders should note the added reserved shares and monitor any future grants or vesting events tied to performance or employment milestones.